Leonard S. Schleifer
2011
In 2011, Leonard S. Schleifer earned a total compensation of $10.6M as President and Chief Executive Officer at Regeneron Pharmaceuticals, a 39% increase compared to previous year.
Compensation breakdown
| Bonus | $2,214,100 |
|---|---|
| Option Awards | $7,450,200 |
| Salary | $785,900 |
| Other | $112,461 |
| Total | $10,562,661 |
Schleifer received $7.5M in option awards, accounting for 71% of the total pay in 2011.
Schleifer also received $2.2M in bonus, $785.9K in salary and $112.5K in other compensation.
Rankings
In 2011, Leonard S. Schleifer's compensation ranked 334th out of 10,747 executives tracked by ExecPay. In other words, Schleifer earned more than 96.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 334 out of 10,747 | 97th |
Division Manufacturing | 109 out of 3,960 | 97th |
Major group Chemicals And Allied Products | 24 out of 1,033 | 98th |
Industry group Drugs | 14 out of 781 | 98th |
Industry Pharmaceutical Preparations | 12 out of 571 | 98th |
Source: SEC filing on April 24, 2014.
Schleifer's colleagues
We found three more compensation records of executives who worked with Leonard S. Schleifer at Regeneron Pharmaceuticals in 2011.
News
Regeneron Pharmaceuticals Executive Vice President and General Manager, Industrial Operations and Product Supply Daniel Van Plew's 2021 pay rises 1% to $8.8M
April 21, 2022
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2020 pay jumps 531% to $135M
April 23, 2021
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2019 pay slips 19% to $21M
April 24, 2020
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2018 pay stays at $27M
April 26, 2019